Joseph Shulman, Chief Technical Officer at RHYTHM PHARMACEUTICALS, INC. (RYTM), sold 8,376 shares at $100.07 ($838K) on 2025-08-21, disclosed to the SEC on 2025-08-25.
Scheduled sale ($838k) by Chief Technical Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $100.07 | 4,188 | $419K | 50.0% |
| 2 | $100.07 | 4,188 | $419K | 50.0% |
| Total | $100.07 avg | 8,376 | $838K | 100% |
| Filing → |
| RYTM | SELL | 2025-10-30 | $648K | — | Filing → |
| RYTM | SELL | 2025-10-20 | $3.2M | — | Filing → |
| RYTM | SELL | 2025-09-04 | $3.5M | — | Filing → |